Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kun Ping Lu

Showing results (1-10 of 146) with videos related to

Pageof 15
Sort By:
Cancer Cell|October 3, 2003
Prolyl isomerase Pin1 as a molecular target for cancer diagnostics and therapeuticsKun Ping Lu
Trends in Biochemical Sciences|April 15, 2004
Pinning down cell signaling, cancer and Alzheimer's diseaseKun Ping Lu
European Journal of Pharmacology|August 15, 2006
Pathogenic mechanisms in Alzheimer's diseaseLucia Pastorino, Kun Ping Lu
Biochimica Et Biophysica Acta|December 24, 2004
Pinning down phosphorylated tau and tauopathiesJormay Lim, Kun Ping Lu
The Journal of Biological Chemistry|December 18, 2001
A critical role for Pin2/TRF1 in ATM-dependent regulation. Inhibition of Pin2/TRF1 function complements telomere shortening, radiosensitivity, and the G(2)/M checkpoint defect of ataxia-telangiectasia cellsShuji Kishi, Kun Ping Lu
Current Cancer Drug Targets|May 14, 2008
Phosphorylation-specific prolyl isomerase Pin1 as a new diagnostic and therapeutic target for cancerGreg Finn, Kun Ping Lu
Nature Reviews. Molecular Cell Biology|September 20, 2007
The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and diseaseKun Ping Lu, Xiao Zhen Zhou
Molecular Cell|February 24, 2007
Prolyl cis-trans Isomerization as a molecular timer in Crk signalingLinda K Nicholson, Kun Ping Lu
Current Aging Science|August 26, 2010
Pin1: a new genetic link between Alzheimer's disease, cancer and agingJane A Driver, Kun Ping Lu
Science Signaling|June 18, 2024
Pin1-catalyzed conformational regulation after phosphorylation: A distinct checkpoint in cell signaling and drug discoveryKun Ping Lu, Xiao Zhen Zhou
Pageof 15

Showing results (1-10 of 146) with videos related to

Sort By:
Pageof 15
Cancer Cell|October 3, 2003
Prolyl isomerase Pin1 as a molecular target for cancer diagnostics and therapeuticsKun Ping Lu
Trends in Biochemical Sciences|April 15, 2004
Pinning down cell signaling, cancer and Alzheimer's diseaseKun Ping Lu
European Journal of Pharmacology|August 15, 2006
Pathogenic mechanisms in Alzheimer's diseaseLucia Pastorino, Kun Ping Lu
Biochimica Et Biophysica Acta|December 24, 2004
Pinning down phosphorylated tau and tauopathiesJormay Lim, Kun Ping Lu
The Journal of Biological Chemistry|December 18, 2001
A critical role for Pin2/TRF1 in ATM-dependent regulation. Inhibition of Pin2/TRF1 function complements telomere shortening, radiosensitivity, and the G(2)/M checkpoint defect of ataxia-telangiectasia cellsShuji Kishi, Kun Ping Lu
Current Cancer Drug Targets|May 14, 2008
Phosphorylation-specific prolyl isomerase Pin1 as a new diagnostic and therapeutic target for cancerGreg Finn, Kun Ping Lu
Nature Reviews. Molecular Cell Biology|September 20, 2007
The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and diseaseKun Ping Lu, Xiao Zhen Zhou
Molecular Cell|February 24, 2007
Prolyl cis-trans Isomerization as a molecular timer in Crk signalingLinda K Nicholson, Kun Ping Lu
Current Aging Science|August 26, 2010
Pin1: a new genetic link between Alzheimer's disease, cancer and agingJane A Driver, Kun Ping Lu
Science Signaling|June 18, 2024
Pin1-catalyzed conformational regulation after phosphorylation: A distinct checkpoint in cell signaling and drug discoveryKun Ping Lu, Xiao Zhen Zhou
Pageof 15